Skip to content

KATALYST Life Sciences: what changed

BE 0760.501.477NACE 72.101, Research and development on biotechnologyOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€6,729
2024 · €53,914-€60,643
Equity
€317,784
2024 · €324,513-€6,729
Cash
€68,146
2024 · €337,497-€269,352
Balance sheet total
€320,875
2024 · €377,246-€56,371

Largest movements

2024 to 2025
Assets
  • Cash -€269,352

    down €269,352 (-79.8%), from €337,497 to €68,146

    mainly Current investments (-€239,718) and Other debts (-€44,475)

  • Current investments +€239,718

    first reported in 2025, at €239,718

  • Receivables within one year -€27,441

    down €27,441 (-85.3%), from €32,156 to €4,715

    of which Other amounts receivable: -€23,438

Equity and liabilities
  • Other debts -€44,475

    down €44,475 (-98.8%), from €45,000 to €525

  • Profit (loss) carried forward -€6,729

    down €6,729 (-75.5%), from €8,914 to €2,185

Income statement
  • Gross operating margin -€71,952

    down €71,952, from €67,096 to -€4,856

  • Taxes -€7,750

    down €7,750 (-95.2%), from €8,138 to €388

  • Financial income +€3,087

    up €3,087 (+1,829%), from €169 to €3,256

  • Depreciation -€1,522

    down €1,522 (-40.7%), from €3,743 to €2,221

  • Financial charges +€1,405

    up €1,405 (+748%), from €188 to €1,592

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €53,914
Gross operating margin -€71,952
Depreciation +€1,522
Other operating charges +€355
Financial income +€3,087
Financial charges -€1,405
Taxes +€7,750
Result 2025 -€6,729
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€28,434
Investment -€240,918
Financing €0
Cash 2024 €337,497
Net result for the year -€6,729
Depreciation +€2,221
Receivables within one year +€27,441
Deferred charges and accrued income -€1,725
Trade debts -€1,451
Tax, wage and social debts -€3,716
Other debts -€44,475
Investment in fixed assets (net) -€1,200
Current investments -€239,718
Cash 2025 €68,146
brings cash intakes cash out
Every line side by side 36 lines
Line Code 2024 2025 Change %
Total assets 20/58 €377,246 €320,875 -€56,371 -14.9%
Fixed assets 21/28 €7,248 €6,227 -€1,021 -14.1%
Tangible fixed assets 22/27 €7,248 €6,227 -€1,021 -14.1%
Furniture and vehicles 24 €7,248 €6,227 -€1,021 -14.1%
Current assets 29/58 €369,997 €314,648 -€55,350 -15.0%
Amounts receivable within one year 40/41 €32,156 €4,715 -€27,441 -85.3%
Trade receivables 40 €4,002 €0 -€4,002 -100%
Other amounts receivable 41 €28,154 €4,715 -€23,438 -83.3%
Current investments 50/53 - €239,718 +€239,718
Cash at bank and in hand 54/58 €337,497 €68,146 -€269,352 -79.8%
Deferred charges and accrued income 490/1 €344 €2,069 +€1,725 +501%
Total equity and liabilities 10/49 €377,246 €320,875 -€56,371 -14.9%
Equity 10/15 €324,513 €317,784 -€6,729 -2.1%
Contributions 10/11 €3,000 €3,000 = 0.0%
Reserves 13 €312,599 €312,599 = 0.0%
Distributable reserves 133 €312,599 €312,599 = 0.0%
Profit (loss) carried forward 14 €8,914 €2,185 -€6,729 -75.5%
Amounts payable 17/49 €52,733 €3,091 -€49,642 -94.1%
Amounts payable within one year 42/48 €52,733 €3,091 -€49,642 -94.1%
Trade debts 44 €3,698 €2,247 -€1,451 -39.2%
Suppliers 440/4 €3,698 €2,247 -€1,451 -39.2%
Taxes, remuneration and social security 45 €4,035 €319 -€3,716 -92.1%
Taxes 450/3 €4,035 €319 -€3,716 -92.1%
Other amounts payable 47/48 €45,000 €525 -€44,475 -98.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €3,743 €2,221 -€1,522 -40.7%
Other operating charges 640/8 €1,283 €928 -€355 -27.7%
Gross operating margin 9900 €67,096 -€4,856 -€71,952
Operating profit (loss) 9901 €62,071 -€8,005 -€70,076
Financial income 75/76B €169 €3,256 +€3,087 +1,829%
Recurring financial income 75 €169 €3,256 +€3,087 +1,829%
Financial charges 65/66B €188 €1,592 +€1,405 +748%
Recurring financial charges 65 €188 €1,592 +€1,405 +748%
Profit (loss) for the period before taxes 9903 €62,052 -€6,341 -€68,393
Income taxes 67/77 €8,138 €388 -€7,750 -95.2%
Profit (loss) for the period 9904 €53,914 -€6,729 -€60,643
Profit (loss) for the period to be appropriated 9905 €53,914 -€6,729 -€60,643

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€371,967 to €457,197

Midpoint €407,479 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €317,784
Capitalised earnings €426,150 to €596,610
Indication €371,967 to €457,197

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€317,784
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€317,784

Capitalised earnings

net result for the year (9904)
2025
-€6,729
2024
€53,914
2023
€131,797
2022
€101,496
2021
€79,305
Average result
€59,661
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€426,150 / €497,175 / €596,610

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 17 November 2026 via checked.be.